Your session is about to expire
← Back to Search
Mindfulness Based Pain Reduction for Chronic Lower Back Pain (MBPR Trial)
MBPR Trial Summary
This trial is testing a new mindfulness-based pain reduction program to see if it's more effective than the existing mindfulness-based stress reduction program.
- Chronic Lower Back Pain
MBPR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MBPR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a smartphone.Only adults 18 years old and older are being enrolled in the study because the program is for adults, not children.Your average pain in the last month needs to be at least a 3 out of 10 on a pain scale. If your pain is less than that, it may be too mild to see if the treatment helps.You have or had an infection, tumor, fracture, or nerve issue in your spine.You have severe vision or hearing problems, bipolar or major depression without medication, substance abuse, dementia, or difficulty getting up and down from the floor, which might make it hard for you to take part in the study.You have serious medical conditions like untreated hypothyroidism, kidney failure, or cirrhosis, which could affect the study results.You are involved in a legal case related to your back, or have complicated legal issues that could influence your reporting of improvement.You are currently pregnant, breastfeeding, or planning to become pregnant soon, or have recently given birth.You do not have a stable place to live, or you plan to move away in the next 6 months.You have had pain in your lower back for at least half of the days in the past 6 months, as shown by specific questions and a drawing of the pain area.If you have had back pain for more than three months and it has bothered you at least half the days in the past 6 months, you may be eligible for the study.You have any of the following: a pacemaker, metal fragments in your body, history of specific medical procedures, certain medical devices, vision problems that can't be corrected, or difficulties lying still for about an hour. These can cause issues during the MRI scan.You have a medical or mental health condition that might make it hard for you to take part in the study, or that may require immediate changes in your medical care that could affect the study results. This includes certain conditions like specific types of cancer, liver failure, and others listed. If you have significant substance abuse or mental health conditions that interfere with daily life, you might not be able to participate. If you need immediate surgery or have unstable medical conditions, you may not be eligible for the study.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Group 1: Group 2
- Group 2: Group 1
Frequently Asked Questions
What is the cap on participants in this research project?
"Indeed, clinicaltrials.gov states that this medical trial is still recruiting patients since first posted on December 14th 2021 and last modified October 13th 2022. 50 individuals are needed to be recruited from 1 particular site in order for the study to continue."
Is recruitment still open for this experiment?
"Affirmative, clinicaltrials.gov attests that this research initiative is currently searching for participants. It was initially posted on December 14th 2021 and the latest update was published October 13th 2022. 50 individuals must be recruited from a single medical centre."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger